Treatment patterns and satisfaction in patients with type 2 diabetes newly initiating oral monotherapy with antidiabetic drugs in Japan: results from the prospective Real-world Observational Study on Patient Outcomes in Diabetes (RESPOND) (vol 10, e003032, 2022)

被引：0
|
作者：
不详
机构：
来源：
BMJ OPEN DIABETES RESEARCH & CARE | 2023年 / 11卷 / 02期
关键词：
D O I：
10.1136/bmjdrc-2022-003032corr1
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页数：1
相关论文
共 50 条
  • [1] Treatment patterns and satisfaction in patients with type 2 diabetes newly initiating oral monotherapy with antidiabetic drugs in Japan: results from the prospective Real-world Observational Study on Patient Outcomes in Diabetes (RESPOND)
    Tajima, Atsushi
    Tobe, Keisuke
    Eiki, Jun-ichi
    Origasa, Hideki
    Watada, Hirotaka
    Shimomura, Iichiro
    Tokita, Shigeru
    Kadowaki, Takashi
    BMJ OPEN DIABETES RESEARCH & CARE, 2022, 10 (06)
  • [2] Real-world Observational Study on Patient Outcomes in Diabetes (RESPOND): study design and baseline characteristics of patients with type 2 diabetes newly initiating oral antidiabetic drug monotherapy in Japan
    Yabe, Daisuke
    Higashiyama, Hiroko
    Kadowaki, Takashi
    Origasa, Hideki
    Shimomura, Iichiro
    Watada, Hirotaka
    Tobe, Keisuke
    Iglay, Kristy
    Tokita, Shigeru
    Seino, Yutaka
    BMJ OPEN DIABETES RESEARCH & CARE, 2020, 8 (02)
  • [3] Real-World Treatment Patterns Among Patients with Type 2 Diabetes Mellitus Initiating Treatment with Oral Semaglutide
    Swift, Caroline
    Frazer, Monica S.
    Gronroos, Noelle N.
    Sargent, Andrew
    Leszko, Michael
    Buysman, Erin
    Alvarez, Sara
    Dunn, Tyler J.
    Noone, Josh
    Guevarra, Mico
    DIABETES THERAPY, 2024, 15 (07) : 1547 - 1559
  • [4] The INITIATOR study: real-world treatment patterns and outcomes in patients with type 2 diabetes initiating insulin glargine or liraglutide
    Levin, P. A.
    Wei, W.
    Buysman, E.
    Thayer, S.
    Brekke, L.
    Crown, W. H.
    Grabner, M.
    Ke, X.
    Quimbo, R. A.
    Cziraky, M. J.
    Hu, W.
    Cuddihy, R.
    Chu, J. W.
    DIABETOLOGIA, 2014, 57 : S53 - S54
  • [5] A real-world study of treatment patterns and outcomes in US managed-care patients with type 2 Diabetes initiating injectable therapies
    Wei, Wenhui
    Buysman, Erin
    Grabner, Michael
    Xie, Lin
    Brekke, Lee
    Ke, Xuehua
    Chu, James W.
    Levin, Philip A.
    DIABETES OBESITY & METABOLISM, 2017, 19 (03): : 375 - 386
  • [6] Real-world outcomes of initiating insulin glargine-based treatment versus premixed analog insulins among US patients with type 2 diabetes failing oral antidiabetic drugs
    Baser, Onur
    Tangirala, Krishna
    Wei, Wenhui
    Xie, Lin
    CLINICOECONOMICS AND OUTCOMES RESEARCH, 2013, 5 : 497 - 505
  • [7] A Retrospective Real-World Study of Dapagliflozin Versus Other Oral Antidiabetic Drugs Added to Metformin in Patients with Type 2 Diabetes
    Huang, Huan
    Bell, Kelly F.
    Gani, Ray
    Tugwell, Cathy W.
    Eudicone, James M.
    Krukas-Hampel, Michelle R.
    AMERICAN JOURNAL OF MANAGED CARE, 2018, 24 (08): : S132 - S137
  • [8] The Real-World Observational Prospective Study of Health Outcomes with Dulaglutide and Liraglutide in Type 2 Diabetes Patients (TROPHIES): Baseline Patient-Reported Outcomes
    Boye, Kristina S.
    Sapin, Helene
    Garcia-Perez, Luis-Emilio
    Rosilio, Myriam
    Orsini Federici, Marco
    Heitmann, Elke
    Jung, Heike
    Aigner, Ulrich
    Guerci, Bruno
    Giorgino, Francesco
    Norrbacka, Kirsi
    DIABETES THERAPY, 2020, 11 (10) : 2383 - 2399
  • [9] THE REAL-WORLD OBSERVATIONAL PROSPECTIVE STUDY OF HEALTH OUTCOMES WITH DULAGLUTIDE AND LIRAGLUTIDE IN TYPE 2 DIABETES PATIENTS (TROPHIES): PATIENT-REPORTED OUTCOMES AT BASELINE
    Boye, K.
    Garcia-Perez, L. E.
    Sapin, H.
    Rosilio, M.
    Federici, Orsini M.
    Heitmann, E.
    Jung, H.
    Gentilella, R.
    Aigner, U.
    Guerci, B.
    Giorgino, F.
    Norrbacka, K.
    VALUE IN HEALTH, 2019, 22 : S593 - S593
  • [10] The Real-World Observational Prospective Study of Health Outcomes with Dulaglutide and Liraglutide in Type 2 Diabetes Patients (TROPHIES): Baseline Patient-Reported Outcomes
    Kristina S. Boye
    Hélène Sapin
    Luis-Emilio García-Pérez
    Myriam Rosilio
    Marco Orsini Federici
    Elke Heitmann
    Heike Jung
    Ulrich Aigner
    Bruno Guerci
    Francesco Giorgino
    Kirsi Norrbacka
    Diabetes Therapy, 2020, 11 : 2383 - 2399
12345